ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Ralph Yarborough, Senator Who Initiated National Cancer Act, Dead at 92

February 2, 1996

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

Obituaries: Paul Carbone; John Eisenberg; Paul Grotzinger

March 15, 2002

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

CALG Loses Pediatrics Grant

July 20, 1979

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975